Approval · Notice of Compliance 16130 · 2014
CLINDETS: Notice of Compliance 16130
Issued September 24, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16130
- Date
- September 24, 2014
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing updates
- Therapeutic class
- Topical acne therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLINDETS | 02243050 | Cancelled Post Market |
Medicinal ingredients
- CLINDAMYCIN PHOSPHATE 1 PER